Literature DB >> 35387923

Is Combination Therapy the Key for Treatment of Heart Failure With Mid-Range or Preserved Ejection Fraction?

Daichi Maeda1, Yuya Matsue1, Tohru Minamino1,2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35387923     DOI： 10.1253/circj.CJ-22-0143

Source DB:  PubMed          Journal:  Circ J        ISSN： 1346-9843            Impact factor:   3.350


× No keyword cloud information.
  1 in total

1.  Association between class of foundational medication for heart failure and prognosis in heart failure with reduced/mildly reduced ejection fraction.

Authors:  Miyuki Ito; Daichi Maeda; Yuya Matsue; Yasuyuki Shiraishi; Taishi Dotare; Tsutomu Sunayama; Kazutaka Nogi; Makoto Takei; Tomoya Ueda; Maki Nogi; Satomi Ishihara; Yasuki Nakada; Rika Kawakami; Nobuyuki Kagiyama; Takeshi Kitai; Shogo Oishi; Eiichi Akiyama; Satoshi Suzuki; Masayoshi Yamamoto; Keisuke Kida; Takahiro Okumura; Yuji Nagatomo; Takashi Kohno; Shintaro Nakano; Shun Kohsaka; Tsutomu Yoshikawa; Yoshihiko Saito; Tohru Minamino
Journal:  Sci Rep       Date:  2022-10-05       Impact factor: 4.996
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.